Navigation Links
Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
Date:8/28/2008

Seven Korean medical centers to collaborate on studies of immunosuppression

in kidney transplant patients and role of cell-mediated immunity

COLUMBIA, Md., Aug. 28 /PRNewswire/ -- "Cylex, Inc., in association with our Korean distributor, Sun Woo Biotech, is delighted to be able to announce our support for a major, multi-center trial of the ImmuKnow assay for cell-mediated immunity at seven highly respected medical institutions in the Republic of Korea," stated Brad Stewart, president of Cylex. "It is a critical goal for the Company to be able to demonstrate the effectiveness of the ImmuKnow assay in transplant populations of different ethnicities by working with specialized institutions around the world."

In the Republic of Korea, a multi-center consortium of kidney transplant centers will use the ImmuKnow assay to assess cell-mediated immunity of 238 patients between the ages of 15 and 60 who undergo an initial kidney transplant and who are randomly assigned to receive either triple immunosuppressive therapy (tacrolimus + mycophenolate mofetil + prednisone) or steroid-free immunosuppression (tacrolimus + mycophenolate mofetil only).

The seven institutions that will participate in this clinical trial include:

-- Samsung Medical Center (in Seoul)

-- KangNam St. Mary's Hospital (in Seoul)

-- Kyungpook National University Hospital (in Daegu)

-- Ajou University Hospital (in Suwon)

-- Daejeon St. Mary's Hospital (in Daegeon)

-- Soon Chun Hyang University Hospital (in Seoul)

-- Bong Seng Memorial Hospital (in Busan)

The ImmuKnow assay will be used to monitor all patients over a period of 36 months from initiation of treatment to assess the value of the assay predicting risk for organ rejection, in predicting risk for infection, and managing patients' immunosuppressed status with a goal of optimizing survival and minimizing organ rejection. Patients will have blood drawn and tested mon
'/>"/>

SOURCE Cylex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
2. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
3. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
5. CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
8. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
9. Genmab Announces Upcoming Ofatumumab Studies
10. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
11. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013 The ... first portable, hand held device for the non-invasive ... the human body. It replaces expensive, time consuming ... of a button, the Biozoom scanner reflects a ... Carl Zeiss—and measures the reflection. Using the scanner, ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... , June 17, 2013 Perrigo Company ... it has signed a definitive agreement to acquire and ... and solution product portfolio from Fera Pharmaceuticals, LLC and ... New York -based specialty pharmaceutical company. The acquired ... $30 million in net revenues during calendar year 2012. ...
Breaking Medicine Technology:University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 2Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 3
... Inc. (Nasdaq: ECTE ), a company developing ... continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep ... is initiating clinical studies of its Symphony tCGM System ... and announce the results of the studies in the ...
...   OncoSec Medical Inc. (OTCBB:ONCS), which is ... (OMS) ElectroOncology therapies to treat solid tumor cancers, ... Officer at OncoSec, will be presenting at the ... 25-26, 2012. (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients 2Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients 3OncoSec to Present at World Cancer Immunotherapy Conference 2OncoSec to Present at World Cancer Immunotherapy Conference 3
(Date:6/17/2013)... June 17, 2013 The distribution of ... traumatic brain injury (MTBI) closely resembles that found in ... online in the journal Radiology. , “Findings of ... early Alzheimer’s dementia,” said the study’s lead author, Saeed ... of Neuroradiology at the University of Pittsburgh School of ...
(Date:6/17/2013)... Vince Del Monte and Ben Pakulski are running a ... and it will only be around for the next 4 days. ... has released an updated Hypertrophy Max review to help people understand ... review here . , Davids says, "Vince Del Monte and Ben ... day sale as an extra incentive for people to take action. ...
(Date:6/17/2013)... BROOK, Ill. In a study of more than ... the abdominal aorta the amount of plaque in ... are associated with future cardiovascular events, such as a ... published online in the journal Radiology . , ... atherosclerosis in an artery outside the heart is an ...
(Date:6/17/2013)... Ill. The distribution of white matter brain abnormalities ... closely resembles that found in early Alzheimer,s dementia, according ... Radiology . , "Findings of MTBI bear ... dementia," said the study,s lead author, Saeed Fakhran, M.D., ... at the University of Pittsburgh School of Medicine. "Additional ...
(Date:6/17/2013)... boosted the number of people who registered themselves as ... researchers found, suggesting social media might be an effective ... United States. , The gains were made in May ... for users to share their organ donor status with ... official on state department of motor vehicle websites. The ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:Updated Hypertrophy Max Review Released for Vince Del Monte and Ben Pakulski's Hypertrophy Max Training Program 2Health News:Atherosclerosis in abdominal aorta may signal future heart attack, stroke 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3
... FRANCISCO A further analysis of a previously published ... study of children with mild persistent asthma reports the ... children with differing demographic and clinical characteristics. ... in the TReating Children to Prevent Exacerbations of Asthma ...
... flu shot during pregnancy provides unanticipated benefits to the ... study examining the issue. Specifically, the study showed that ... significantly reduced risk of stillbirth, preterm birth and extremely ... Hospital Research Institute (OHRI), the CHEO Research Institute and ...
... , MONDAY, May 21 (HealthDay News) -- In a scenario ... found a way to perform nearly surgery-free gastric bypass procedures ... done with moveable magnets, is completed in less than a ... leaving behind any foreign material. Although pigs may not ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... used in some artificial sweeteners, may worsen Crohn,s disease by ... intestine, a new study suggests. However, researchers stressed that ... the lab, not in people, so it,s too soon to ...
... including a scientist from the Viral Immunology Center at ... herpesvirus infection of the eye is associated with neovascular ... in the elderly. The scientists found that human ... vascular endothelial growth factor, or VEGF, a signal protein ...
... to see that University of Cincinnati design students Alex Broerman ... design and prototype for a prescription-medicine pill bottle that better ... means of a simple and inexpensive innovation. In fact, ... their design a design intended to have universal appeal ...
Cached Medicine News:Health News:Baseline characteristics of children with mild persistent asthma predict response to ICS 2Health News:Flu shot during pregnancy shows unexpected benefits in large study 2Health News:Moveable Magnets Used to Forge Gastric Bypass in Pigs 2Health News:Moveable Magnets Used to Forge Gastric Bypass in Pigs 3Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 2Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 3Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:UC students design a better pill bottle for the blind and visually impaired 2Health News:UC students design a better pill bottle for the blind and visually impaired 3
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: